文献速递外周动脉疾病

因慢性肢体威胁性缺血行下肢旁路术后,黑人或非裔美国患者阿片类药物处方模式的差异

Discrepancy in opioid prescription patterns for Black or African American patients following lower extremity bypass surgery for chronic limb-threatening ischemia.
PubMed 文献 · J Vasc Surg · 2024-08-14

基于TrinetX数据库2000至2023年的回顾性分析,纳入3345例因慢性肢体威胁性缺血行下肢旁路术的成人患者,比较白人(2661例)与黑人或非裔美国人(684例)出院后阿片类药物处方率。黑人或非裔美国患者出院后7天和30天阿片处方率均显著低于白人,调整混杂因素后差异仍存在。

要点

  • 黑人或非裔美国患者出院后7天阿片处方率33.2%,低于白人的42.5%(P<.05)。
  • 出院后30天阿片处方率黑人或非裔美国患者35.8%,低于白人的47.2%(P<.05)。
  • 按疾病分期分层后,黑人或非裔美国患者阿片处方率在各期均低于白人。

核心结论

  • 因慢性肢体威胁性缺血行下肢旁路术后,黑人或非裔美国患者在出院后7天和30天接受阿片类药物处方的可能性低于白人患者。

研究设计与样本

  • 回顾性分析,使用TrinetX数据库2000至2023年因慢性肢体威胁性缺血行下肢旁路术的成人患者。
  • 共纳入3345例患者,白人组(I组)2661例,黑人或非裔美国人组(II组)684例。
  • 主要结局为出院后7天和30天口服阿片类药物处方及术后1年死亡率;次要结局包括住院时长和30天术后结局。
  • 采用两样本t检验和χ2检验进行单变量分析,并采用逻辑回归控制相关术前潜在混杂因素。

主要发现

  • 出院后7天阿片处方率黑人或非裔美国人组33.2% vs 白人组42.5%(P<.05);30天为35.8% vs 47.2%(P<.05)。
  • 按适应证分层,7天静息痛43.4% vs 33.7%(P=.013)、溃疡41.4% vs 31.7%(P=.027)、坏疽42.7% vs 33.6%(P=.006)。
  • 30天静息痛47.8% vs 37.1%(P=.007)、溃疡45.4% vs 33.5%(P=.007)、坏疽48.2% vs 36.1%(P<.001)。
  • 调整分析显示,黑人或非裔美国人种族与较低的7天(调整比值比0.607;P=.001)和30天(调整比值比0.56;P=.001)出院后阿片处方率相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Disparity in the allocation of medical services and resources based on race is present within the health care industry today, including the prescription of postoperative analgesics. The purpose of this study was to evaluate the presence of race-based disparity in the prescription of postdischarge opioids after lower extremity bypass (LEB) surgery for chronic limb-threatening ischemia (CLTI). METHODS: Retrospective analysis was conducted on adult CLTI patients who underwent LEB from 2000 to 2023 in the TrinetX database. Patients were stratified into two groups based on race: White (group I) and black or African American (AA) (group II). Primary outcomes were defined as oral opioid prescriptions at 7 days and 30 days after discharge, and mortality at 1 year postoperatively. Secondary outcomes included length of stay and 30-day postoperative outcomes, including myocardial infarction, pulmonary embolism, cerebral vascular accident, deep vein thrombosis, acute kidney injury, major amputation, minor amputation, major adverse cardiac events, and major adverse limb events. Stratified analysis was conducted based on disease stage (rest pain vs lower extremity ulcer vs gangrene). Univariate analysis was performed via two-sample t test and χ2 test. Logistic regression was performed to estimate the association of Black or AA (vs White) race while controlling for pertinent preoperative potential confounders. RESULTS: There were 3345 patients who met the inclusion criteria. Group I included 2661 White patients and group II included 684 Black or AA patients. Group II patients were more likely to be younger, female, present with gangrene, and have a history of hypertension, diabetes, chronic kidney disease, or diabetic neuropathy. At both 7 and 30 days after discharge, the Black or AA cohort had significantly lower rates of opioid prescriptions (33.2% vs 42.5% and 35.8% vs 47.2%, respectively) (all P < .05). Stratification by indication showed that opioid prescription disparity persisted despite black or AA patients presenting at worse stages of disease both at 7 and 30 days after discharge (7 days: rest pain 43.4% vs 33.7% [P = .013], ulcer 41.4% vs 31.7% [P = .027], gangrene, 42.7% vs 33.6% [P = .006] and 30 days: rest pain 47.8% vs 37.1% [P = .007], ulcer 45.4% vs 33.5% [P = .007], gangrene, 48.2% vs 36.1% [P < .001]). Adjusted analysis confirmed that Black or AA race was associated with lower rates of 7- (adjusted odds ratio, 0.607; P = .001) and 30-day (adjusted odds ratio, 0.56; P = .001) postdischarge opioid prescriptions. CONCLUSIONS: Black or AA patients were less likely to receive postdischarge opioid prescriptions compared with their White counterparts at 7 and 30 days after LEB for CLTI.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lavanga E, Samaan F, DeHaven C, et al. Discrepancy in opioid prescription patterns for Black or African American patients following lower extremity bypass surgery for chronic limb-threatening ischemia. J Vasc Surg. 2024. PMID: 39151741. doi:10.1016/j.jvs.2024.08.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。